Photodynamic activity of a glucoconjugated silicon(IV) phthalocyanine on human colon adenocarcinoma

Cancer Biology and Therapy

Volumn 10, Issue 2, 2010, Pages 126-134

  Chan, Crystal M H ^a   Lo, Pui Chi ^a   Yeung, Sin Lui ^a   Ng, Dennis K P ^a   Fong, Wing Ping ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Cancer; Photodynamic therapy; Photosensitizer; Phthalocyanine

Indexed keywords

CASPASE 3; CYTOCHROME C; GLUCOCONJUGATED SILICON PHTHALOCYANINE; GLUCOSE REGULATED PROTEIN 78; LIPOCORTIN 5; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; COLON ADENOCARCINOMA; CONFOCAL MICROSCOPY; CYTOSOL; DRUG DISCRIMINATION; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LYSOSOME MEMBRANE; MITOCHONDRION; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION;

EID: 77955447810     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.2.11946     Document Type: Article

References (36)

1. Triesscheijn M, Baas P, Schellens JH, Stewart FA. Photodynamic therapy in oncology. Oncologist 2006; 11:1034-44.
2. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004; 5:497-508. (Pubitemid 39069400)
3. Okunaka T, Kato H, Konaka C, Furukawa K, Harada M, Yamamoto Y. Photodynamic therapy of lung cancer with bronchial artery infusion of Photofrin. Diagn Ther Endosc 1996; 2:203-6.
4. Roberts WG, Smith KM, McCullough JL, Berns MW. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem Photobiol 1989; 49:431-8.
5. Allen CM, Sharman WM, van Lier JE. Current status of phthalocyanines in the photodynamic therapy of cancer. J Porphyr Phthalocyanines 2001; 5:161-9.
6. Patrice T. Photodynamic Therapy. Cambridge: Royal Society of Chemistry 2004; 260.
7. Filonenko EV, Sokolov VV, Chissov VI, Lukyanets EA, Vorozhtsov GN. Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn Ther 2008; 5:187-90.
8. Miller JD, Baron ED, Scull H, Hsia A, Berlin J, McCormick T, et al. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 2007; 224:290-9.
9. Lee TK, Baron ED, Foster TH. Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy. J Biomed Opt 2008; 13:030507.
10. Yslas EI, Prucca C, Romanini S, Durantini EN, Bertuzzi M, Rivarola V. Biodistribution and phototherapeutic properties of zinc(II) 2,9,16,23- tetrakis(methoxy) phthalocyanine in vivo. Photodiagnostis Photodyn Ther 2009; 6:62-70.
11. Iqbal Z, Lyubimtsev A, Hanack M, Ziegler T. Anomerically glycosylated zinc(II) naphthalocyanines. Tetrahedron Lett 2009; 50:5681-5.
12. Soares ARM, Tome JPC, Neves MGPMS, Tome AC, Cavaleiro JAS, Torres T. Synthesis of water-soluble phthalocyanines bearing four or eight D-galactose units. Carbohydr Res 2009; 344:507-10.
13. Taquet J, Frochot C, Manneville V, Barberi-Heyob M. Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy. Curr Med Chem 2007; 14:1673-87.
14. Lo PC, Chan CMH, Liu JY, Fong WP, Ng DKP. Highly photocytotoxic glucosylated silicon(IV) phthalocyanines. Effects of peripheral chloro substitution on the photophysical and photodynamic properties. J Med Chem 2007; 50:2100-7.
15. Banfi S, Caruso E, Buccafurni L, Ravizza R, Gariboldi M, Monti E. Zinc phthalocyanines-mediated photodynamic therapy induces cell death in adenocarcinoma cells. J Organomet Chem 2007; 692:1269-76.
16. Shen HM, Shi CY, Shen Y, Ong CN. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic Biol Med 1996; 21:139-46.
17. Varnes ME, Chiu SM, Xue LY, Oleinick NL. Photodynamic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation. Biochem Biophys Res Commun 1999; 255:673-9.
18. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta 2006; 1757:509-17.
19. Pavani C, Uchoa AF, Oliveira CS, Iamamoto Y, Baptista MS. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers. Photochem Photobiol Sci 2009; 8:233-40.
20. Fuchs J, Thiele J. The role of oxygen in cutaneous photodynamic therapy. Free Radic Biol Med 1998; 24:835-47.
21. Ball DJ, Mayhew S, Wood SR, Griffiths J, Vernon DI, Brown SB. A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge. Photochem Photobiol 1999; 69:390-6.
22. Lo PC, Huang JD, Cheng DYY, Chan EYM, Fong WP, Ko WH, et al. New amphiphilic silicon(IV) phthalocyanines as efficient photosensitizers for photodynamic therapy: synthesis, photophysical properties and in vitro photodynamic activities. Chemistry 2004; 10:4831-8.
23. Trivedi NS, Wang HW, Nieminen AL, Oleinick NL, Izatt JA. Quantitative analysis of Pc 4: localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy. Photochem Photobiol 2000; 71:634-9.
24. Yslas EI, Durantini EN, Rivarola VA. Zinc-(II) 2,9,16,23- tetrakis(methoxy) phthalocyanine: potential photosensitizer for use in photodynamic therapy in vitro. Bioorg Med Chem 2007; 15:4651-60.
25. Lai JC, Lo PC, Ng DKP, Ko WH, Leung SC, Fung KP, et al. BAM-SiPc, a novel agent for photodynamic therapy, induces apoptosis in human hepatocarcinoma HepG2 cells by a direct mitochondrial action. Cancer Biol Ther 2006; 5:413-8.
26. Maftoum-Costa M, Naves KT, Oliveira AL, Tedesco AC, da Silva NS, Pacheco-Soares C. Mitochondria, endoplasmic reticulum and actin filament behavior after PDT with chloroaluminum phthalocyanine liposomal in HeLa cells. Cell Biol Int 2008; 32:1024-8.
27. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4:552-65.
28. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004; 11:372-80.
29. Marchal S, Francois A, Dumas D, Guillemin F, Bezdetnaya L. Relationship between subcellular localization of Foscan and caspase activation in photosensitised MCF-7 cells. Br J Cancer 2007; 96:944-51.
30. Buytaert E, Dewaele M, Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007; 1776:86-107. (Pubitemid 47332075)
31. Byrne AT, O'Connor AE, Hall M, Murtagh J, O'Neill K, Curran KM, et al. Vascular-targeted photodynamic therapy with BF2-chelated tetraaryl- azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment. Br J Cancer 2009; 101:1565-73.
32. Vittar NBR, Prucca CG, Strassert C, Awruch J, Rivarola VA. Cellular inactivation and antitumor efficacy of a new zinc pththalocyanine with potential use in photodynamic therapy. Int J Biochem Cell Biol 2008; 40:2192-205.
33. Bourre L, Simonneaux G, Ferrand Y, Thibaut S, Lajat Y, Patrice T. Synthesis, in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. J Photochem Photobiol B 2003; 69:179-92.
34. Hajri A, Wack S, Meyer C, Smith MK, Leberquier C, Kedinger M, et al. In vitro and in vivo efficacy of Photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol 2002; 75:140-8.
35. Chin W, Lau W, Cheng C, Olivo M. Evaluation of hypocrellin B in human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects. Int J Oncl 2004; 25:623-9.
36. 2 is a consequence of lysosomal rupture. Biochem J 2001; 356:549-55.